☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Immunovant
Immunovant Reports Results of Batoclimab in P-II Trial for the Treatment of Graves’ Disease
December 21, 2023
Immunovant Provides an Update to Initiate P-III Trial of Batoclimab for the Treatment of Myasthenia Gravis
December 31, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.